Covered recipient · General Payments record
JOSEPH MICHEL MEIER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2022
$359.70
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.21 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $60.85 | 4 |
| Lilly USA, LLC | $32.57 | 2 |
| Janssen Pharmaceuticals, Inc | $31.12 | 2 |
| Merck Sharp & Dohme Corporation | $17.49 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.47 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939268921 | CMS |
| Amgen Inc. | $13.82 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939869845 | CMS |
| Amgen Inc. | $15.90 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939268923 | CMS |
| Amgen Inc. | $11.66 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939869847 | CMS |
| Janssen Pharmaceuticals, Inc | $18.54 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886248525 | CMS |
| Janssen Pharmaceuticals, Inc | $12.58 | 11/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886248531 | CMS |
| Lilly USA, LLC | $18.17 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918129597 | CMS |
| Lilly USA, LLC | $14.40 | 10/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918093377 | CMS |
| Merck Sharp & Dohme LLC | $17.49 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944147331 | CMS |
| Novartis Pharmaceuticals Corporation | $16.18 | 09/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893964703 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.